BOPA Passport and UTIC

Over the next few days we will rolling out an update to the current Passport content based on user feedback and errors highlighted. This includes updates to MCQs and a new element in the core module – UTIC.  The UTIC course (Understanding Targeted therapies and Immunotherapies for Cancer), delivered by Elaine Vickers, will be a compulsory core component for Passport users going forward, and as an optional learning component to those already registered (it will not be shown in the passport but can be completed as extra).

 

This course is available via the BOPA website and the ISOPP website. After completion of the 5 modules, you will be awarded a certificate, which can be uploaded to the BOPA Passport as evidence.  For more information on the course visit: https://www.bopa.org.uk/utic/

 

The Passport Pillar wish to thank the membership for their involvement in ensuring the Passport content is relevant and correct and welcome ongoing feedback. Please send any queries or comments to: [email protected]

 

Sarah Mitchell (BOPA Passport Lead and Clinical Pharmacist | Beatson West of Scotland Cancer Centre )

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article